USPTO serial 79975865
GOLD STANDARD DIAGNOSTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 28, 2025
- Examiner
- THOMPSON, HEATHER
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GOLD STANDARD DIAGNOSTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
EUROFINS SCIENTIFIC (IRELAND) LIMITED
IE
Other trademarks owned by EUROFINS SCIENTIFIC (IRELAND) LIMITED
EUROFINS SCIENTIFIC (IRELAND) LIMITED
IE
Other trademarks owned by EUROFINS SCIENTIFIC (IRELAND) LIMITED
EUROFINS SCIENTIFIC (IRELAND) LIMITED
IE
Other trademarks owned by EUROFINS SCIENTIFIC (IRELAND) LIMITED
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joseph Sofer
Joseph Sofer Ipsilon USA, LLP110 West 40th StreetSuite 2001New York, NY 10018Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic preparations for medical and veterinary use; diagnostic reagents for medical and veterinary use; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely infectious disease, auto-immune diseases, oncology, hormone disorders for medical and veterinary use ; chemical reagents for carrying out analytical tests for medical and veterinary purposes; chemical reagents for medical and veterinary use; chemical preparations for medical and veterinary use, namely for microbiology, for detecting epidemiological risks, infectious diseases or auto-immune diseases, for supporting vaccines ; organic chemical reagents for medical or veterinary use; analytical and diagnostic testing kits for medical and veterinary use comprising diagnostic reagents and assays; PCR kits, namely analytical and diagnostic test kits for medical use consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; PCR kits, namely, reagents and control samples for medical or veterinary diagnostic purposes; analytical standard solutions for detection of chemical and biochemical molecules for medical diagnostic and veterinary diagnostic use; chemically-modified magnetic beads for binding chemical or biochemical compounds for detection of chemical and biochemical compounds for medical diagnostic and veterinary diagnostic use; diagnostic test kits comprising proteins, polypeptides and chemical reagents for medical and veterinary purposes. | ACTIVE | — |
| 009 | Medical laboratory measuring apparatus, diagnostic apparatus, and analysis apparatus, namely, Enzyme-Linked Immunosorbent Assay (ELISA) test readers, Enzyme-Linked Immunosorbent Assay (ELISA) analyzers, lateral flow test strip readers, photometers, liquid analyzers, nanoparticle size analyzers, infrared spectrometers, and nuclear magnetic resonance (NMR) spectroscopy apparatus, not for medical use; Diagnostic medical laboratory equipment, namely sample containers and tubes for samples for medical and veterinary use; sample containers and sample devices for scientific and laboratory use; Downloadable software for establishment, systematization, evaluation and/or collection of analytical or diagnostic data; DNA microchips; peptide microchips in the nature of DNA microchips; DNA microarrays; peptide microarrays; Biochips for research or scientific purposes; laboratory instruments for analysis and diagnosis not for medical use, namely, test tubes; scientific laboratory apparatuses and instruments, namely, test strip readers, magnetic separators, and automated analysis apparatuses comprising an optical reader for microplates; scientific apparatus and instruments, namely, non-automated analysis apparatus comprising an optical and microplate reader, a tape microplate reader, a test strip reader, a tube reader, a photometer, a microplate reader for scientific, laboratory, or industrial use and not for medical diagnostic use; scientific laboratory apparatuses and instruments for measuring the concentration of analytes from aqueous samples for scientific, laboratory, or industrial use not for medical diagnostic use. | ACTIVE | — |
| 010 | Computerized medical and veterinary recording and analysis apparatus for the diagnosis and treatment of infectious disease, auto-immune diseases, oncology, hormone disorders; Diagnostic medical laboratory equipment, namely test sample containers and tubes for samples for medical and veterinary use; Test sample containers and sample preparation devices for diagnostic medical and veterinary use; test kits for medical analysis and diagnosis for medical and veterinary use, namely, test sample collection tubes; Test sample collection kits for medical analysis and diagnostics for medical and veterinary use, namely tubes, stoppers ; test strips, lancets; Test box comprising test sample collection tubes; medical diagnostic apparatus in the nature of blotters for Guthrie testing; medical diagnostic apparatus and instruments, namely, test strip readers, magnetic separators, automated analysis apparatus comprising an optical reader for microplates for medical and veterinary diagnostic use; medical diagnostic apparatus and instruments, namely, non-automated analysis apparatus comprising an optical microplate reader, a strip microplate reader, a test strip reader, a tube reader, a photometer, a microplate reader for medical and veterinary diagnostic use; medical diagnostic apparatus and instruments for measuring the concentration of analytes from aqueous samples for medical and veterinary diagnostic use; Medical diagnostic Enzyme-Linked Immunoabsorbant Assay (ELISA) and other antibody-based kits, namely, test bands and strips, microtiter plates, coated test tubes and magnetic particles for the detection of chemical and biochemical and biological molecules or parts thereof for medical and veterinary diagnostic use. | ACTIVE | — |
| 042 | Scientific research and industrial research in the fields of animal and plant biology, physical chemistry, microbiology, molecular biology, epidemiology, immunology, chemistry, biochemistry, pharmacology, cosmetic, biopharmaceutical, biotechnology, nutraceutical, food and feed industries; Scientific research and development in the fields of animal and plant biology, physical chemistry, food chemistry, microbiology, molecular biology, epidemiology, immunology, chemistry, biochemistry; Scientific research in the nature of carrying out physical, chemical, physico-chemical, biochemical, biological, epidemiological, microbiological, molecular biological, or immunological analyses in the fields of plant and animal products; Scientific research in the nature of performance of physical analyses, chemical, physico-chemical, biochemical, biological, epidemiological, microbiological, molecular biological, or immunological, and clinical and in vitro studies, in the food, animal food, agri-food, chemical, pharmaceutical, cosmetic, health, environmental, agrochemical, biotechnology and any other science related industry; Scientific research in the nature of carrying out genetic analyses in the fields of plant and animal products; Scientific research in the nature of carrying out genetic analyses in the field of the food, feed, agri-food, chemical, pharmaceutical, cosmetic, health, biotechnology and consumer product, and environmental testing industries; Scientific research and development of methods, namely, establishing and conducting physical, chemical, physical-chemical, biochemical, organic, epidemiological, microbiological, molecular biological, immunological and biomolecular testing methods; preparing scientific research reports, industrial research expert reports for scientists and engineers in the field of animal and plant biology, physical chemistry, microbiology, molecular biology, epidemiology, immunology, chemistry, biochemistry, pharmacology, cosmetic, biopharmaceutical, biotechnology, nutraceutical, food and feed industries; DNA, RNA and virus testing for scientific research purposes; consultation and advisory services relating to product development in the field of goods manufactured by the pharmaceutical, chemical, biotechnology, and any other science-related industry; product development consultation and advisory services for developing product manufacturing; research and development of new products in the pharmaceutical, biotechnological, chemical and agro-chemical fields; Scientific research services in the areas of genomics, proteomics, chemistry, pharmacology, biology, epidemiology, medicinal chemistry, organic and inorganic chemistry, synthetic chemistry, analogue chemistry and computational chemistry; Providing scientific research information in the fields of epidemiology, genomics and proteomics of living organisms including human beings based on existing biological data and using computer tools and techniques; scientific and technological services, namely, scientific and medical research laboratory services, medical laboratory research and product research and development in the fields of epidemiology, biomedicine and biobanks; Design and testing for new product development for veterinary products and their applications. | ACTIVE | — |
| 044 | Medical services for diagnostic or treatment purposes, namely blood analysis, saliva, urine, tissue, hair and body fluid analysis services; Medical testing for diagnostic or treatment purposes, namely serology and urinary testing for medical, epidemiological and veterinary purpose; medical testing services in the fields of epidemiology and genetics for diagnostic or treatment purposes; medical and health care services related to DNA and RNA; genetic analysis for medical diagnostic or treatment use; medical assistance and medical services in the fields of epidemiology and genetics; medical clinic services; collection, sampling and preservation of human blood, saliva, urine, tissues, hair and body fluids for medical diagnostic or treatment purposes; medical testing services for diagnostic and epidemiological purposes; medical diagnostic testing, monitoring and reporting in the field of cardiovascular disease; medical testing for diagnostic and treatment purposes, namely, for the genetic causes of lipid abnormalities; medical diagnostic testing in the field of diabetes; medical testing for diagnostic purposes in the fields of preventive medicine; medical services, namely, preventive medicine and testing in the field of micro-nutrition; medical diagnostic testing in the field of anti-aging medicine; medical assistance services in the field of preventive medicine; Providing medical information in the nature of bio-pathological information and advice relating to medical biology testing; conducting tests to determine immunogenicity, hypersensitivity and adverse immune stimulation for medical diagnostic or treatment purposes; conducting allergy and immunology tests for medical diagnostic or treatment purposes; infectious disease testing for medical diagnostic or treatment purposes; conducting prenatal diagnostic tests for medical diagnostic purposes; conducting prenatal diagnostic tests for treatment purposes. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EUROFINS SCIENTIFIC (IRELAND) LIMITED
- Other trademarks owned by EUROFINS SCIENTIFIC (IRELAND) LIMITED
- Other trademarks owned by EUROFINS SCIENTIFIC (IRELAND) LIMITED
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named GOLD STANDARD DIAGNOSTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 6, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 29, 2026 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| May 29, 2026 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jan 28, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 26, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 28, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 28, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 6, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 5, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 5, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 5, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 6, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 20, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 20, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 13, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 13, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 13, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 28, 2025 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jan 14, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 8, 2025 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jan 8, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 8, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 8, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 8, 2025 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jul 28, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 10, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 10, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 21, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 20, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 19, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 23, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 17, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 2, 2024 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Dec 21, 2023 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |